Development and characterization of [ 99m Tc]Tc-lornoxicam as a potential COX-assisted radiopharmaceutical for inflammation imaging
Year: 2026
Type: article
Abstract: Tc]Tc-lornoxicam demonstrated a high labeling yield, satisfactory stability, moderate lipophilicity, and preferential inflammation-associated localization. These findings support the potential of the radiotracer as a COX-targeted radiopharmaceutical for inflammation imaging, although further molecular investigations are warranted to establish its COX-specific targeting mechanism.
Source: RSC Advances
DOI: 10.1039/d6ra08252a
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,042
OpenAlex ID: W7220839332
